KX-826 , a small change in the pipeline
    Research/Science 2/10/2026

    At a glance
    In this research discussion post, the primary subjects mentioned are
    ๐Ÿ’ง KX-826 (topical) 0.5% and 1.0% BID
    โ€ข Finasteride
    ๐Ÿ’ง Clascoterone (topical)
    ๐Ÿ’ง Minoxidil (topical) 5% 2x daily 5 weeks
    ๐Ÿ’ง Dermarolling (topical) 1x weekly
    the tone is ๐Ÿ˜ neutral with modest improvements results.
    KX-826 is undergoing trials for hair loss treatment, showing similar effectiveness between 0.5% and 1.0% dosages, with mild side effects compared to finasteride. Users discuss combining KX-826 with other treatments like minoxidil and clascoterone for better results.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 369 results

      community 1 year on fin. No results. I give up.

      in Finasteride/Dutasteride  43 upvotes 3 years ago
      A user who has been taking finasteride, minoxidil, and microneedling for one year with no results, and the replies discuss other treatments, including dutasteride, which is feared due to potential side effects.

      community KX-826 Pyrilutamide1% coming soon

      in Update  152 upvotes 1 year ago
      KX-826 Pyrilutamide 1% is launching soon, and users are discussing its potential benefits and drawbacks compared to other treatments like Minoxidil and finasteride. Some users are skeptical about its effectiveness, while others are hopeful it will be a safer alternative.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  444 upvotes 3 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

    Related Research

    6 / 175 results